Novel Mycobacterium tuberculosis specific HLA-A*0201 restricted T cell epitopes in Tb patients
Novel Mycobacterium tuberculosis specific HLA-A*0201 restricted T cell epitopes in Tb patients
Marc Jacobsen1, Helmy Rachman1, Andrea Gutschmidt1, Jörg Hakenberg2, Hans J. Mollenkopf1, Albert Neher3, Knut Feldmann4, Stefan H.E. Kaufmann1
1 Max-Planck-Insitute for Infection Biology, Dept.
of Immunology, 10117 Berlin, Germany;
2 Humboldt-University, Institute for Computer Science, Dept.
Knowledgemanagement in Bioinformatics, 12489 Berlin, Germany;
3 Institute of Laboratory Medicine, Asklepios Clinics,
Gauting, Germany
;
4 Zentralkrankenhaus Gauting, Germany;
* Corresponding author. Present adress:
Max-Planck-Institute for Infection Biology, 10117 Berlin,
Germany.
Abstract
Previous studies suggested an important role for CD8+ T
cells in the host defense against Mycobacterium tuberculosis
(M.tb), the etiologic agent for human tuberculosis. To further
characterize this host response we focused on M.tb specific
proteins determined by genome comparison of twelve different
mycobacterial species performing microarray analysis. Genome comparison
confirmed by PCR analysis revealed seven genes which were identified to
be exclusive in M.tb. We employed the MAPPP (MHC-class I
Antigenic Peptide Processing Prediction) program to predict immunogenic
peptides from these proteins. Restrictive criteria for proteasome
cleavage and HLA-A*0201 binding revealed 92 peptides probably
recognized by CD8+ T cells. These 9-10mer peptides and seven
described immunodominant HLA-A*02 restricted M.tb epitopes
were commercially synthesized and tested in short term immune cell
assays for their capability to induce IFN-γ in peripheral blood
mononuclear cells (PBMCs) from tuberculosis patients, PPD+
and PPD- control donors. Intracellular IFN-γ straining and
ELISPOT analysis revealed two peptides RLRRDNAEL (Rv795) and
VLYDECDTL (Rv2655c) which stimulated CD8+ memory t
cells only from tuberculosis patients. About 30% of the HLA-matched
patients hah peptide specific T cells and the amount was approximately
0.1% of CD8+ T cells. Nearly identical results were observed
for the described immunogenic peptides VLTDGNPPEV (19-kDa
protein), GLPVEYLQV (Antigen 85A), and KLAGGVAVI
(Mhsp65). PBMCs from control donors showed no reactivity with any
peptide.
Our investigations revealed two novel M.tb specific epitopes
which induce IFN-γ expression in CD8+ T cells from
tuberculosis patients predicted by MAPPP. Further studies will
determine the frequency of these immune cells during disease course and
the role of the mycobacterial proteins coded by the genes Rv795 and
Rv2655c in the host response against M.tb infection
Links
- MAPPP - MHC-class I Antigenic Peptide Processing Prediction
- Website